zometa

The bone-building drug Zometa does not appear to prevent breast cancer from coming back in most women, researchers report.

SAN ANTONIO (AP) -- Doctors are reporting a stunning setback for a promising new approach for fighting breast cancer....

Adding the intravenous bone drug Zometa to chemotherapy improves survival in patients with the blood cancer multiple myeloma, new research from the U.K. shows.

WASHINGTON AP) (AP) -- In an Oct. 21 story about drug labels, The Associated Press erroneously described the Novartis drug Zometa.

Zometa was approved in 2001 to treat excessive calcium levels, not to treat a form of osteoporosis in cancer patients.

Also, the drug was approved only in a 4 milligram dose, not in both 4 milligram and 8 milligram doses. A corrected version of the story appears below....

CHICAGO (AP) -- A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new way to fight the disease....